Literature DB >> 12860474

Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.

Paul Aoun1, David G Watson, James W Simpkins.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are involved in regulating many metabolic and inflammatory processes. The present study explores the role of PPAR ligands in protecting neuronal cultures from toxic insults. For that purpose, we used WY14643 [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio acetic acid] as a PPARalpha agonist, L-165041 and L-783483 as PPARbeta ligands, and 15-deoxy-Delta(12,14)-PGJ2 (15d-PGJ2), troglitazone, and ciglitazone for PPARgamma. Experiments were performed using HT-22, an immortalized mouse hippocampal cell line, and SK-N-SH, a human neuroblastoma cell line. Cell viability against glutamate, hydrogen peroxide (H(2)O(2)), and serum deprivation insults was determined using a calcein acetoxymethyl (AM) assay. Of the compounds tested, only 15d-PGJ2 and troglitazone showed a dose-dependent neuroprotection from glutamate and H(2)O(2) insults in HT-22 cells. None of the PPAR agonists was protective in SK-N-SH cells. A minimum of 4-6 h preincubation with 15d-PGJ2 was required to achieve significant neuroprotection. On the other hand, troglitazone was protective even when administered simultaneously with glutamate, or for up to 8 h postglutamate insult. To investigate whether the neuroprotective effects are mediated through PPARgamma, we first determined through Western blotting that HT-22 and SK-N-SH cells express PPARgamma. However, the neuroprotective effects of those compounds are unlikely to be mediated through the PPARgamma for two reasons: (1) various concentrations of another PPARgamma agonist (ciglitazone) were not neuroprotective; (2) by itself, PPAR exhibits a low affinity for DNA, and high-affinity binding requires heterodimerization with RXR, the 9-cis-retinoic acid receptor; administering 9-cis-retinoic acid in conjunction with 15d-PGJ2 did not alter the neuroprotective effects of the latter. Our results demonstrate neuroprotective effects of 15d-PGJ2 and troglitazone that are likely independent of PPARgamma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860474     DOI: 10.1016/s0014-2999(03)01867-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Plate reader-based assays for measuring cell viability, neuroprotection and calcium in primary neuronal cultures.

Authors:  Stephanie L Burroughs; R Scott Duncan; Parvathi Rayudu; Prasanthi Kandula; Andrew J Payne; Julie L Clark; Peter Koulen; Simon Kaja
Journal:  J Neurosci Methods       Date:  2011-09-24       Impact factor: 2.390

2.  Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.

Authors:  Tristano Pancani; Jeremiah T Phelps; James L Searcy; Michael W Kilgore; Kuey-Chu Chen; Nada M Porter; Olivier Thibault
Journal:  J Neurochem       Date:  2009-05-11       Impact factor: 5.372

3.  Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-κB/NLRP3 inflammasome axis.

Authors:  Mei-Ting Song; Jie Ruan; Ru-Yi Zhang; Jie Deng; Zhan-Qiang Ma; Shi-Ping Ma
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

4.  Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection.

Authors:  Erwan Thouennon; Yong Cheng; Vida Falahatian; Niamh X Cawley; Yoke Peng Loh
Journal:  J Neurochem       Date:  2015-06-01       Impact factor: 5.372

5.  The omega-6 fatty acid derivative 15-deoxy-Δ¹²,¹⁴-prostaglandin J2 is involved in neuroprotection by enteric glial cells against oxidative stress.

Authors:  Hind Abdo; Maxime M Mahé; Pascal Derkinderen; Kalyane Bach-Ngohou; Michel Neunlist; Bernard Lardeux
Journal:  J Physiol       Date:  2012-04-02       Impact factor: 5.182

6.  Monochloramine-induced toxicity and dysregulation of intracellular Zn2+ in parietal cells of rabbit gastric glands.

Authors:  Jonathan E Kohler; J Matthew Dubach; Haley B Naik; Kaniza Tai; Amy L Blass; David I Soybel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

7.  Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis.

Authors:  Jonathan E Kohler; Amy L Blass; Jingjing Liu; Kaniza Tai; David I Soybel
Journal:  Free Radic Biol Med       Date:  2010-06-08       Impact factor: 7.376

Review 8.  Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.

Authors:  Erik S Musiek; Ginger L Milne; BethAnn McLaughlin; Jason D Morrow
Journal:  Brain Pathol       Date:  2005-04       Impact factor: 6.508

Review 9.  Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.

Authors:  Ramya Kapadia; Jae-Hyuk Yi; Raghu Vemuganti
Journal:  Front Biosci       Date:  2008-01-01

10.  Effects of long-term pioglitazone treatment on peripheral and central markers of aging.

Authors:  Eric M Blalock; Jeremiah T Phelps; Tristano Pancani; James L Searcy; Katie L Anderson; John C Gant; Jelena Popovic; Margarita G Avdiushko; Don A Cohen; Kuey-Chu Chen; Nada M Porter; Olivier Thibault
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.